HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

mono-isobutyl phthalate

Networked: 10 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Carbocyclic Acids
    - Phthalic Acids: 1
      - mono-isobutyl phthalate: 10

Experts

1.	Calafat, Antonia M: 2 articles (01/2022 - 11/2019)
2.	Cordero, José F: 2 articles (01/2022 - 11/2019)
3.	Ferguson, Kelly K: 2 articles (01/2022 - 11/2019)
4.	McElrath, Thomas F: 2 articles (01/2022 - 11/2019)
5.	Meeker, John D: 2 articles (01/2022 - 11/2019)
6.	Rosen, Emma M: 2 articles (01/2022 - 11/2019)
7.	Aalborg, Jenny: 1 article (01/2022)
8.	Alshawabkeh, Akram N: 1 article (01/2022)
9.	Baird, Donna D: 1 article (01/2022)
10.	Barrett, Emily S: 1 article (01/2022)

Related Diseases

1.	Premature Birth (Birth, Premature) 11/01/2019 - "An IQR increase in mono-isobutyl phthalate (MiBP), a metabolite of DiBP, was associated with 1.16 days shorter gestation (95% CI = -2.25, -0.08) and an OR of 1.32 (95% CI: 1.02, 1.71) for preterm birth. " 01/01/2022 - "Higher odds of preterm birth, ranging from 12% to 16%, were observed in association with an interquartile range increase in urinary concentrations of mono-n-butyl phthalate (odds ratio [OR], 1.12 [95% CI, 0.98-1.27]), mono-isobutyl phthalate (OR, 1.16 [95% CI, 1.00-1.34]), mono(2-ethyl-5-carboxypentyl) phthalate (OR, 1.16 [95% CI, 1.00-1.34]), and mono(3-carboxypropyl) phthalate (OR, 1.14 [95% CI, 1.01-1.29]). "
2.	Nephrolithiasis 10/01/2023 - "Furthermore, high-level exposure to mono-isobutyl phthalate had a similar positive association with nephrolithiasis (P = 0.028). "
3.	Hyperuricemia 03/01/2023 - "Compared to the lowest quantile, the odds ratios (ORs) and 95% confidence intervals (CIs) for hyperuricemia were all statistically significant in following phthalate metabolites: 1.34 (1.13-1.58) for the second quartile in Mono-isobutyl phthalate (MiBP), 1.21 (1.01-1.46) for the highest quartile in Mono-(carboxyoctyl) phthalate (MCOP), 0.66 (0.56-0.76) for the second quartile in Mono-(2-ethyl)-hexyl phthalate (MEHP), 1.22 (1.05-1.43) for quartile 2 in Benzyl butyl phthalate (ΣBBP), and 1.43 (1.22-1.66) for the third quartile in high molecular-weight phthalate (ΣHigh MWP), respectively. "
4.	Obesity 01/01/2020 - "In the multivariable logistic regression model, 2,5-dichlorophenol (2,5-DCP) (OR (95% CI): 1.25 (1.11, 1.40)), monoethyl phthalate (MEP) (OR (95% CI): 1.28 (1.04, 1.58)), and mono-isobutyl phthalate (MiBP) (OR (95% CI): 1.42 (1.07, 1.89)) were found to be positively associated with obesity, while methylparaben (MeP) (OR (95% CI): 0.80 (0.68, 0.94)) was negatively associated with obesity. "
5.	Insulin Resistance 10/20/2019 - "Moreover, urinary mono-methyl phthalate (MMP), mono-isobutyl phthalate (MiBP), and bisphenol S (BPS) levels showed positive associations with the homeostasis model assessment for insulin resistance (HOMA-IR). "

Related Drugs and Biologics

1.	phthalic acid (phthalate)
2.	Matrix Metalloproteinases (MMPs)
3.	mono-benzyl phthalate
4.	ORALIT (ORS)
5.	monobutyl phthalate
6.	mono-(2-ethylhexyl)phthalate
7.	Dibutyl Phthalate (Butyl Phthalate)
8.	monoethyl phthalate
9.	bis(4-hydroxyphenyl)sulfone
10.	mono(2-ethyl-5-hydroxyhexyl) phthalate